Home > Insider Trading > Filing (0001426395-20-000004)

Filing Details

Accession Number:: 0001426395-20-000004
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-02-19 20:37:50
Reporting Period:: 2020-02-18

Accepted Time:: 2020-02-19 20:37:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1689923	Alteryx Inc.	AYX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1426395	M Christopher Lal	C/O Alteryx, Inc. 3345 Michelson Drive, Suite 400 Irvine CA 92612	Clo & Corp. Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2020-02-18	4,380	$0.00	20,956	No	4	C	Direct
Class A Common Stock	Acquisiton	2020-02-18	1,460	$68.26	22,416	No	4	M	Direct
Class A Common Stock	Disposition	2020-02-18	223	$154.22	22,193	No	4	S	Direct
Class A Common Stock	Disposition	2020-02-18	717	$155.53	21,476	No	4	S	Direct
Class A Common Stock	Disposition	2020-02-18	929	$156.57	20,547	No	4	S	Direct
Class A Common Stock	Disposition	2020-02-18	1,908	$157.60	18,639	No	4	S	Direct
Class A Common Stock	Disposition	2020-02-18	1,339	$158.65	17,300	No	4	S	Direct
Class A Common Stock	Disposition	2020-02-18	724	$159.61	16,576	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class B Common Stock	Stock Option (Right to Buy)	Disposition	2020-02-18	4,380	$0.00	4,380	$12.30
Class A Common Stock	Class B Common Stock	Acquisiton	2020-02-18	4,380	$0.00	4,380	$0.00
Class A Common Stock	Class B Common Stock	Disposition	2020-02-18	4,380	$0.00	4,380	$0.00
Class A Common Stock	Stock Option (Right to Buy)	Disposition	2020-02-18	1,460	$0.00	1,460	$68.26

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,738	2026-11-28	No	4	M	Direct
4,380		No	4	M	Direct
0		No	4	C	Direct
16,473	2029-03-03	No	4	M	Direct

Footnotes

Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date
Includes (i) 12,248 unvested shares subject to awards of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020.
Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.91 to $154.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.04 to $155.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.08 to $156.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.15 to $158.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.15 to $159.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.22 to $159.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
The stock option vested and became exercisable as to 1/4th of the shares subject to the option on November 29, 2017, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the earliest to occur of the following: (a) the date specified by a vote of the holders of 66 2/3% of the outstanding shares of Class B Common Stock, (b) March 23, 2027, and (c) the date the shares of Class B Common Stock cease to represent at least 10% of all outstanding shares of Common Stock. The shares of Class A Common Stock and Class B Common Stock have no expiration date.
The stock option vested and became exercisable as to 1/3rd of the shares subject to the option on January 1, 2020, and thereafter vests as to 1/36th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.